Our biological understanding of TGCTs has been improved using sequencing, and molecular profiles associated with the genomic evolution and development of cisplatin resistance have been identified. The genomics of variants underpinning TGCT predisposition is being delineated. Studies of circulating microRNAs have demonstrated their potential for noninvasive diagnosis and disease monitoring.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Transient effects of chemotherapy for testicular cancer on mouse behaviour
Scientific Reports Open Access 23 June 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bagrodia, A. et al. Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors. J. Clin. Oncol. 34, 4000–4007 (2016).
Litchfield, K. et al. Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours. Nat. Commun. 6, 5973 (2015).
Taylor-Weiner, A. et al. Genomic evolution and chemoresistance in germ-cell tumours. Nature 540, 114–118 (2016).
Murray, M. J. et al. Identification of microRNAs from the miR-371∼373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am. J. Clin. Pathol. 135, 119–125 (2011).
Murray, M. J., Huddart, R. A. & Coleman, N. The present and future of serum diagnostic tests for testicular germ cell tumours. Nat. Rev. Urol. 13, 715–725 (2016).
Dieckmann, K. P. et al. Serum Levels of microRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours. Eur. Urol. 71, 213–220 (2017).
van Agthoven, T. & Looijenga, L. H. J. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test). Oncotarget 8, 58037–58049 (2017).
Litchfield, K. et al. Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility. Nat. Commun. 7, 13840 (2016).
Litchfield, K. et al. Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor. Nat. Genet. 49, 1133–1140 (2017).
Wang, Z. et al. Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. Nat. Genet. 49, 1141–1147 (2017).
Acknowledgements
M.J.M. acknowledges grant funding from The St Baldrick's Foundation and the Isaac Newton Trust. M.J.M is grateful for support from the Max Williamson Fund and from Christiane and Alan Hodson, in memory of their daughter Olivia. C.T. acknowledges support from the Movember foundation.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Murray, M., Turnbull, C. Sequencing advances understanding. Nat Rev Urol 15, 79–80 (2018). https://doi.org/10.1038/nrurol.2017.209
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.209
This article is cited by
-
Transient effects of chemotherapy for testicular cancer on mouse behaviour
Scientific Reports (2020)